These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Itskovitz HD Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316 [TBL] [Abstract][Full Text] [Related]
3. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. Titmarsh S; Monk JP Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169 [TBL] [Abstract][Full Text] [Related]
4. Review of the use of alpha-adrenoceptor antagonists in hypertension. Stokes GS; Marwood JF Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Djavan B; Marberger M Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649 [TBL] [Abstract][Full Text] [Related]
6. New perspectives on selective alpha 1 blockade. Luther RR Am J Hypertens; 1989 Sep; 2(9):729-35. PubMed ID: 2572243 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study. Lepor H; Jones K; Williford W J Urol; 2000 Apr; 163(4):1134-7. PubMed ID: 10737482 [TBL] [Abstract][Full Text] [Related]
8. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Prichard BN Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891 [TBL] [Abstract][Full Text] [Related]
9. Alpha- and beta-receptor blocking drugs in the treatment of hypertension. Ram CV; Kaplan NM Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755 [TBL] [Abstract][Full Text] [Related]
11. New-onset priapism associated with ingestion of terazosin in an otherwise healthy man. Sadeghi-Nejad H; Jackson I J Sex Med; 2007 Nov; 4(6):1766-8. PubMed ID: 17451488 [TBL] [Abstract][Full Text] [Related]
12. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Lowe FC Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists. Reid JL; Vincent J Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958 [TBL] [Abstract][Full Text] [Related]
14. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein. Kincaid-Smith P J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178 [TBL] [Abstract][Full Text] [Related]
15. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. Na YJ; Guo YL; Gu FL J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165 [TBL] [Abstract][Full Text] [Related]
16. The value of alpha-blockers in the management of hypertension: a practical view. McInnes GT J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406 [No Abstract] [Full Text] [Related]
17. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. Sakakibara R; Hattori T; Uchiyama T; Suenaga T; Takahashi H; Yamanishi T; Egoshi K; Sekita N J Auton Nerv Syst; 2000 Mar; 79(2-3):191-5. PubMed ID: 10699651 [TBL] [Abstract][Full Text] [Related]
18. Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers. Belayneh M; Korownyk C Can Fam Physician; 2016 Sep; 62(9):e523. PubMed ID: 27629686 [No Abstract] [Full Text] [Related]
19. Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia. Plosker GL; Goa KL Pharmacoeconomics; 1997 Feb; 11(2):184-97. PubMed ID: 10165827 [TBL] [Abstract][Full Text] [Related]